BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld
Home
» Pyxis, Theseus star in latest wave of biopharma IPOs
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Pyxis, Theseus star in latest wave of biopharma IPOs
Oct. 8, 2021
By
Michael Fitzhugh
No Comments
Highlighting 2021's clear trajectory toward record IPO territory, Oct. 8 brought upsized market debuts for both Pyxis Oncology Inc. and Cognition Therapeutics Inc., raising $168 million and $45.2 million, respectively.
BioWorld
Financings
IPO